Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06517498

Disease Burden and Living Situation of Patients With Facioscapulohumeral Muscular Dystrophy

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Xi'an Jiaotong University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to learn the patient journey, disease burden, living situation, quality of life and etc. in patients with Facioscapulohumeral Muscular Dystrophy in all sex/gender and age groups. The main questions it aims to answer are: 1. What's the patient journey of patients with Facioscapulohumeral Muscular Dystrophy? 2. How does Facioscapulohumeral Muscular Dystrophy burden the patients? 3. How's the quality of life of patients with Facioscapulohumeral Muscular Dystrophy? Patients with Facioscapulohumeral Muscular Dystrophy will be asked to: 1. fill a questionnaire. 2. be interviewed and answer questions about their illness experience, economic burden, quality of life and etc. Medical experts on Facioscapulohumeral Muscular Dystrophy will be asked to be interviewed and answer questions about understanding on the disease and the patients.

Detailed description

Study Objective This observational study aims to comprehensively understand the patient journey, disease burden, living situation, and quality of life in individuals diagnosed with Facioscapulohumeral Muscular Dystrophy (FSHD). The study encompasses all sex/gender and age groups to provide a holistic view of the disease's impact. Research Questions The study focuses on answering the following key questions: 1. What is the patient journey of individuals with Facioscapulohumeral Muscular Dystrophy? 2. How does Facioscapulohumeral Muscular Dystrophy burden the patients? 3. What is the quality of life of patients with Facioscapulohumeral Muscular Dystrophy? Methodology To gather comprehensive data, participants will be engaged in two main activities: 1.Questionnaire Completion: Participants will fill out a detailed questionnaire designed to capture quantitative data on their health status, symptoms, treatments received, and the impact of FSHD on their daily lives. The questionnaire will also collect demographic information and other relevant background data. 2.In-Depth Interviews with patients with Facioscapulohumeral Muscular Dystrophy: They will undergo semi-structured interviews conducted by trained researchers. These interviews will delve into the personal experiences of living with FSHD, including: 1. Illness Experience: Participants will describe their journey from initial symptoms to diagnosis and ongoing management of the disease. 2. Economic Burden: Discussions will cover the financial impact of FSHD, including costs related to medical care, treatments, and any income loss due to the inability to work. 3. Quality of Life: Interviews will explore the effects of FSHD on various life domains, such as physical health, mental well-being, social relationships, and overall life satisfaction. 3.In-Depth Interviews with medical experts on Facioscapulohumeral Muscular Dystrophy: They will undergo semi-structured interviews conducted by trained researchers. These interviews will delve into their understanding on the disease and the patients. Expected Outcomes The study aims to generate a detailed understanding of the multifaceted impact of FSHD on patients' lives. By examining the patient journey, disease burden, and quality of life, the study seeks to identify gaps in current healthcare provisions and areas where additional support may be needed. This information will be valuable for healthcare providers, policymakers, and patient support organizations in improving care and support for individuals with FSHD.

Conditions

Interventions

TypeNameDescription
OTHERNo InterventionNo Intervention will be conducted

Timeline

Start date
2024-03-01
Primary completion
2025-03-01
Completion
2025-07-01
First posted
2024-07-24
Last updated
2024-07-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06517498. Inclusion in this directory is not an endorsement.